Masaki Nomura
Overview
Explore the profile of Masaki Nomura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirayama M, Hatou S, Nomura M, Hokama R, Hirayama O, Inagaki E, et al.
Cell Rep Med
. 2025 Jan;
6(1):101847.
PMID: 39809262
A first-in-human investigator-initiated clinical study of a corneal endothelial cell substitute (CLS001) derived from a clinical-grade induced pluripotent stem cell (iPSC) line shows improvement of visual acuity and corneal stromal...
2.
Aoyama Y, Yamazaki H, Nishimua K, Nishimura K, Nomura M, Shigehiro T, et al.
Blood
. 2025 Jan;
145(11):1149-1163.
PMID: 39775457
The maintenance of cellular redox balance is crucial for cell survival and homeostasis and is disrupted with aging. Selenoproteins, comprising essential antioxidant enzymes, raise intriguing questions about their involvement in...
3.
Soma T, Oie Y, Takayanagi H, Matsubara S, Yamada T, Nomura M, et al.
Lancet
. 2024 Nov;
404(10466):1929-1939.
PMID: 39522528
Background: The loss of corneal epithelial stem cells from the limbus at the edge of the cornea has severe consequences for vision, with the pathological manifestations of a limbal stem-cell...
4.
Kunitomi A, Hirohata R, Osawa M, Washizu K, Arreola V, Saiki N, et al.
Stem Cell Reports
. 2024 May;
19(5):710-728.
PMID: 38701780
Heterogeneity among both primed and naive pluripotent stem cell lines remains a major unresolved problem. Here we show that expressing the maternal-specific linker histone H1FOO fused to a destabilizing domain...
5.
Miyagawa S, Kawamura T, Ito E, Takeda M, Iseoka H, Yokoyama J, et al.
Stem Cell Res Ther
. 2024 Mar;
15(1):73.
PMID: 38475911
Background: Cell- or tissue-based regenerative therapy is an attractive approach to treat heart failure. A tissue patch that can safely and effectively repair damaged heart muscle would greatly improve outcomes...
6.
Xiao M, Kondo S, Nomura M, Kato S, Nishimura K, Zang W, et al.
Nat Commun
. 2023 Dec;
14(1):8372.
PMID: 38102116
ATP-dependent chromatin remodeling SWI/SNF complexes exist in three subcomplexes: canonical BAF (cBAF), polybromo BAF (PBAF), and a newly described non-canonical BAF (ncBAF). While cBAF and PBAF regulate fates of multiple...
7.
Tanaka A, Nishimura K, Saika W, Kon A, Koike Y, Tatsumi H, et al.
Leukemia
. 2023 Jul;
37(9):1802-1811.
PMID: 37464069
SETBP1 is a potential epigenetic regulator whose hotspot mutations preventing proteasomal degradation are recurrently detected in myeloid malignancies with poor prognosis. It is believed that the mutant SETBP1 exerts amplified...
8.
Kunitomi A, Hirohata R, Arreola V, Osawa M, Kato T, Nomura M, et al.
Cell Rep Methods
. 2022 Nov;
2(11):100317.
PMID: 36447645
Naive human induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells with Sendai virus (SeV) vectors. However, only dermal fibroblasts have been successfully reprogrammed this way, and...
9.
Kitano Y, Nishimura S, Kato T, Ueda A, Takigawa K, Umekage M, et al.
Mol Ther Methods Clin Dev
. 2022 Jun;
26:15-25.
PMID: 35755947
In order to expand the promise of regenerative medicine using allogeneic induced pluripotent stem cells (iPSCs), precise and efficient genome editing of human leukocyte antigen (HLA) genes would be advantageous...
10.
Tanaka A, Nakano T, Nomura M, Yamazaki H, Bewersdorf J, Mulet-Lazaro R, et al.
Blood
. 2022 Jun;
140(8):875-888.
PMID: 35709354
Detailed genomic and epigenomic analyses of MECOM (the MDS1 and EVI1 complex locus) have revealed that inversion or translocation of chromosome 3 drives inv(3)/t(3;3) myeloid leukemias via structural rearrangement of...